News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Conference News EuroPCR 2021 Transradial PCI Bests Femoral Access in Complex Cases: COLOR Michael O'Riordan May 21, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News TCT 2019 New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing Todd Neale September 28, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News CRT 2019 Blasting Off: Experience Grows for Intravascular Lithotripsy for Coronary Plaque Yael L. Maxwell March 15, 2019
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016